These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 483258)

  • 41. Urokinase localization and activity in isolated eosinophils.
    Mabilat-Pragnon C; Janin A; Michel L; Thomaïdis A; Legrand Y; Soria C; Lu H
    Thromb Res; 1997 Nov; 88(4):373-9. PubMed ID: 9526961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Streptokinase or urokinase: the elements of choice].
    Pâques EP
    Haemostasis; 1986; 16 Suppl 4():21-5. PubMed ID: 2429902
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
    Takada Y; Takada A
    Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
    [No Abstract]   [Full Text] [Related]  

  • 44. Relationship of plasminogen activator to fibrin.
    Chesterman CN; Allington MJ; Sharp AA
    Nat New Biol; 1972 Jul; 238(79):15-7. PubMed ID: 18663837
    [No Abstract]   [Full Text] [Related]  

  • 45. The biphasic nature and temperature dependence of the activation of human plasminogen by urokinase. A simple urokinase assay based on this phenomenon.
    Ambrus CM; Bartfay-Szabo A; Mirand E; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):339-47. PubMed ID: 461988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.
    Whur P; Silcox JJ; Boston JA; Williams DC
    Br J Cancer; 1979 Jun; 39(6):718-30. PubMed ID: 156038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An artificial circulation for the study of thrombolysis. The influence of flow rate and pressure on thrombolysis and a comparison between urokinase and tissue activator as thrombolytic agents.
    Walker JE; Flook V; Ogston D
    Acta Haematol; 1983; 69(1):41-6. PubMed ID: 6401892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibrinogen-fibrin related antigen pattern in human blood. Incomplete lysis of whole blood clots by urokinase.
    Jacobsen CD; Fry GL; Wu KK; Southers NJ
    Thromb Res; 1975 Apr; 6(4):327-36. PubMed ID: 1079637
    [No Abstract]   [Full Text] [Related]  

  • 49. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of plasminogen activator inhibitor-1 release from human cerebral endothelium by plasminogen activators. A factor potentially predisposing to intracranial bleeding.
    Shatos MA; Doherty JM; Penar PL; Sobel BE
    Circulation; 1996 Aug; 94(4):636-42. PubMed ID: 8772682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacology of thrombolytic drugs.
    Verstraete M; Collen D
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):33B-40B. PubMed ID: 3097100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Enzymatic fibrinolytic agents].
    Jamet M; Granthil C; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The search for the ideal thrombolytic agent.
    Verstraete M
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards.
    Brommer EJ
    Thromb Res; 1984 Apr; 34(2):109-15. PubMed ID: 6539513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The rapid fibrin plate - a method for plasminogen activator assay.
    Marsh NA; Gaffney PJ
    Thromb Haemost; 1977 Aug; 38(2):545-51. PubMed ID: 579495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation.
    Geratz JD; Shaver SR; Tidwell RR
    Thromb Res; 1981 Oct 1-15; 24(1-2):73-83. PubMed ID: 6460342
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasminogen activation by receptor-bound urokinase.
    Ellis V; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells.
    Collen D; Billiau A; Edy J; De Somer P
    Biochim Biophys Acta; 1977 Sep; 499(2):194-201. PubMed ID: 198009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.